The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world characterization of advanced/metastatic non-small cell lung cancer (aNSCLC) patients (pts) with rapid disease progression (RDP).
 
Martin Gutierrez
Stock and Other Ownership Interests - COTA
Consulting or Advisory Role - Bayer; Karyopharm Therapeutics; Lilly
Speakers' Bureau - Bristol-Myers Squibb; Foundation One Inc; Lilly; Merck
Research Funding - Abbvie (Inst); Acceleron Pharma (Inst); Bayer (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Daiichi Sankyo (Inst); Eisai (Inst); EMD Serono (Inst); Esanex (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Incyte (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Loxo (Inst); MedImmune (Inst); Merck (Inst); Mirati Therapeutics (Inst); Moderna Therapeutics (Inst); Novartis (Inst); Regeneron (Inst); Rexahn Pharmaceuticals (Inst); Sanofi (Inst); Seagen (Inst); Tesaro (Inst); TG Therapeutics (Inst)
 
Cliff Molife
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Andrew J. Belli
Employment - COTA
Stock and Other Ownership Interests - COTA
Research Funding - COTA
 
Eric Hansen
Employment - COTA
Stock and Other Ownership Interests - Abbvie; Johnson & Johnson
 
Victoria Jennifer Stefaniak
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Katherine B. Winfree
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Zhanglin Lin Cui
Employment - Lilly
Stock and Other Ownership Interests - Lilly
Other Relationship - Lilly
 
Marta Batus
No Relationships to Disclose
 
Jeffrey Melson Clarke
Consulting or Advisory Role - AstraZeneca; Guardant Health
Speakers' Bureau - Guardant Health; Lilly; Merck
Research Funding - Abbvie; Adaptimmune; Bristol-Myers Squibb; Genentech/Roche; medpacto; Moderna Therapeutics; Spectrum Pharmaceuticals
 
Viraj Narayanan
Employment - COTA
Stock and Other Ownership Interests - Celgene; COTA; Medpace; Pfizer
Honoraria - American Journal of Managed Care; HEALTH ADVANCES
Research Funding - COTA (Inst)
Travel, Accommodations, Expenses - COTA
 
Chelsea Manion
Employment - Lilly
Stock and Other Ownership Interests - Lilly
Consulting or Advisory Role - Profero
 
Andrew David Norden
Employment - Cota Healthcare; IBM
Leadership - Cota Healthcare
Consulting or Advisory Role - Bristol-Myers Squibb; Celldex; VBL Therapeutics
 
Philip D. Bonomi
Honoraria - AstraZeneca; Biodesix; Bristol-Myers Squibb; Helsinn Therapeutics; Lilly; Merck; pfizer; Roche/Genentech; Trovagene
Consulting or Advisory Role - AstraZeneca; Biodesix; Bristol-Myers Squibb; Helsinn Therapeutics; Lilly; Merck; Merck; Pfizer; Roche/Genentech
Research Funding - AstraZeneca (Inst); Biodesix (Inst); Bristol-Myers Squibb (Inst); Corvus Pharmaceuticals (Inst); Five Prime Therapeutics (Inst); Lilly (Inst); Merck (Inst); Pfizer (Inst); Roche/Genentech (Inst)